GC-MS/MS systems.

2. Scope

This SOP applies to all mass spectral analyses involving fragmentation studies of small molecules in Analytical Method Development (AMD) laboratories using tandem mass spectrometry (MS/MS) platforms.

3. Responsibilities

• Analytical Scientist: Performs fragmentation studies, interprets MS/MS spectra, and proposes fragmentation pathways.
• MS Specialist: Assists in instrument configuration and data processing setup.
• QA Officer: Reviews documentation and ensures compliance with scientific and regulatory standards.
• Head – AMD: Approves final fragmentation reports and ensures alignment with development objectives.

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that fragmentation analysis supports method development, impurity identification, and is carried out as per regulatory expectations.

5. Procedure

5.1 Sample and Standard Preparation

1. Weigh and dissolve 1–2 mg of analyte in 1 mL of appropriate solvent (acetonitrile, methanol, or water).
2. Filter through 0.22 µm PVDF or PTFE filters before injection.
3. If studying degradation or impurities, prepare stress-degraded samples using acid, base, oxidative, thermal, or photolytic conditions.
4. Document sample prep in Annexure-1: Sample Preparation Log.

5.2 Instrument Configuration

1. Use triple quadrupole or Q-TOF MS systems with Electrospray Ionization (ESI) or APCI interface.
2. Configure precursor ion scan (Q1), fragment scan (Q3), and collision energy ramp.
3. Set up scan modes:
   • Full scan MS (Q1 scan)
   • Product ion scan (MS/MS)
   • Neutral loss scan (optional)
4. Document instrument settings in Annexure-2: Instrument Configuration Sheet.

5.3 Acquisition and Optimization

1. Inject 10 µL of sample into LC-MS/MS system using validated chromatographic conditions.
2. Record full scan spectra to identify parent ion (m/z of interest).
3. Apply varying collision energies (e.g., 10–40 eV) in product ion mode.
4. Capture fragment spectra at multiple energies for robust pathway analysis.
5. Repeat for positive and negative ion modes if applicable.
6. Record parameters and spectra in Annexure-3: Fragmentation Data Log.

5.4 Interpretation of Fragment Ions

1. Identify major fragment ions and determine:
   • Neutral losses (e.g., H₂O, CO, CH₃OH)
   • Stable ring cleavages or chain fragmentations
   • Rearrangement ions or diagnostic ions
2. Use chemical structure drawing software to propose fragmentation pathways.
3. Label fragmentation positions and correlate with known chemical logic.
4. Prepare pathway diagrams in Annexure-4: Fragmentation Scheme Sheet.

5.5 Reporting and Documentation

1. Summarize:
   • Precursor ion and major fragments with m/z values
   • Collision energy and scan parameters
   • Fragmentation mechanism and structural rationale
2. Include:
   • Annotated MS/MS spectra
   • Structure with fragmentation arrows
   • Conclusion on identity or impurity assignment
3. Compile into final report and submit for review.
4. Record final documentation in Annexure-5: Summary Report Log.

6. Abbreviations

• MS/MS: Tandem Mass Spectrometry
• Q-TOF: Quadrupole Time of Flight
• ESI: Electrospray Ionization
• APCI: Atmospheric Pressure Chemical Ionization
• SOP: Standard Operating Procedure

7. Documents

1. Sample Preparation Log – Annexure-1
2. Instrument Configuration Sheet – Annexure-2
3. Fragmentation Data Log – Annexure-3
4. Fragmentation Scheme Sheet – Annexure-4
5. Summary Report Log – Annexure-5

8. References

• ICH Q3A/B – Impurities Guidelines
• FDA Guidance on Mass Spectrometry for Structural Elucidation
• Instrument Manufacturer Manuals for QqQ and Q-TOF Systems

9. SOP Version

Version: 2.0

10. Approval Section

	Prepared By	Checked By	Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Sample Preparation Log

Sample ID	Solvent	Concentration	Filter Type	Prepared By	Date
MSF-108-A	Methanol	1 mg/mL	PTFE 0.22 µm	Rajesh Kumar	18/05/2025

Annexure-2: Instrument Configuration Sheet

Instrument	Ion Source	Mode	Collision Energy Range	Scan Type
Q-TOF LC-MS	ESI	Positive	10–40 eV	Product Ion Scan

Annexure-3: Fragmentation Data Log

Precursor Ion (m/z)	Major Fragments (m/z)	Collision Energy	Comments
332.1	287.0, 149.1, 121.0	30 eV	Consistent with expected cleavage

Annexure-4: Fragmentation Scheme Sheet

[Attach hand-drawn or software-generated fragmentation pathways showing bond cleavage sites and resulting ion structures.]

Annexure-5: Summary Report Log

Sample	Analysis Type	Result Summary	Analyst	Approved By
Compound X	Impurity Structure Elucidation	Identified 2 degradants via MS/MS	Sunita Reddy	Head – AMD

Revision History:

Revision Date	Revision No.	Details	Reason	Approved By
04/05/2025	2.0	Expanded MS/MS modes and fragmentation scheme annexure	Annual SOP Update